-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Pardes Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2020 to Q1 2023.
- Pardes Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$26.5M, a 30.3% decline year-over-year.
- Pardes Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$72M, a 95% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)